Почетна › Мажорна депресивна поремећеност › Охајо
Kliničke studije za Мажорна депресивна поремећеност u državi Охајо
25 studija za Мажорна депресивна поремећеност traži učesnike na lokacijama u državi Охајо.
Gradovi u državi Охајо
Zvanični tekst studije (na engleskom)
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Independence
- Seaport Investigator Site, North Canton
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 10. 11. 2026. · NCT07065240ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Neuro-Behavioral Clinical Research, North Canton
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 5. 11. 2026. · NCT07284667Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Patient Priority Clinical Sites LLC, Cincinnati
- The Ohio State University, Columbus
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 3. 11. 2026. · NCT06559306A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- University of Cincinnati, Cincinnati
Тражи се учесникФаза 3
Узраст од 12 до 17 · Оба пола · Ажурирано 3. 11. 2026. · NCT07227454Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Quest Therapeutics of Avon Lake, Avon Lake
- University of Cincinnati Medical Center, Cincinnati
- The Ohio State University, Columbus
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 3. 11. 2026. · NCT05850689A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Patient Priority Clinical Sites LLC, Cincinnati
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 3. 11. 2026. · NCT07573176Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Avon Lake
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT06966401Study of ALTO-300 in MDD
- Site 202, Cincinnati
Тражи се учесникФаза 2
Узраст од 18 до 70 · Оба пола · Ажурирано 26. 10. 2026. · NCT05922878A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety
- The Ohio State University Department of Psychiatry, Columbus
Тражи се учесникФаза 2
Узраст од 21 до 65 · Оба пола · Ажурирано 20. 10. 2026. · NCT06820723Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- The Cleveland Clinic Foundation, Cleveland
- The Ohio State University, Columbus
Тражи се учесник
Узраст од 22 до 70 · Оба пола · Ажурирано 16. 10. 2026. · NCT06423430A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Columbus
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 14. 10. 2026. · NCT07610473Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Cincinnati
- Clinical Research Site, Cincinnati
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 13. 10. 2026. · NCT07484217Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Cincinnati
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 24. 9. 2026. · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Independence
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT07105111Positive Processes and Transition to Health (PATH)
- Case Western Reserve University, Cleveland
Тражи се учесник
Узраст од 18 до 65 · Оба пола · Ажурирано 19. 8. 2026. · NCT06093906NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Mason
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 11. 8. 2026. · NCT06911112Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Insight Clinical Trials LLC, Independence
Тражи се учесникФаза 2
Узраст од 18 до 64 · Оба пола · Ажурирано 3. 8. 2026. · NCT06547489Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains
- Lindner Center of Hope, Mason
Тражи се учесникФаза 1/2
Узраст од 18 до 60 · Оба пола · Ажурирано 3. 8. 2026. · NCT06795451A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Insight Clinical Trials LLC, Independence
Тражи се учесникФаза 2
Узраст од 18 до 64 · Оба пола · Ажурирано 27. 7. 2026. · NCT07115329A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Quest Therapeutics of Avon /ID# 277550, Avon Lake
- OSU Psychiatry Department /ID# 277529, Columbus
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 15. 6. 2026. · NCT07276997Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation
- Cincinnati Childrens Hospital Medical Center, Cincinnati
Тражи се учесник
Узраст од 14 до 18 · Оба пола · Ажурирано 11. 2. 2026. · NCT07217444Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #109, Beachwood
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 20. 1. 2026. · NCT06633016Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Avon Lake
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2025. · NCT06786624Mechanisms of Rumination Change in Adolescent Depression
- Nationwide Children's Hospital, Columbus
- The Ohio State University, Columbus
Тражи се учесник
Узраст од 14 до 17 · Оба пола · Ажурирано 11. 8. 2025. · NCT03859297A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Cincinnati
Тражи се учесникФаза 4
Узраст од 18 до 65 · Оба пола · Ажурирано 23. 1. 2025. · NCT06223880Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.